We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+6.83%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.32B
AUM Growth
-$100M
Cap. Flow
-$118M
Cap. Flow %
-8.94%
Top 10 Hldgs %
27.68%
Holding
135
New
38
Increased
26
Reduced
44
Closed
22

Sector Composition

Rank Sector Weight
1 Healthcare 93.61%
2 Industrials 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRVI icon
126
Maravai LifeSciences
MRVI
$947M
-978,600
Closed -$27.4M
REPL icon
127
Replimune Group
REPL
$1B
-667,729
Closed -$25.5M
RVMD icon
128
Revolution Medicines
RVMD
$38.8B
-389,006
Closed -$15.4M
SEER icon
129
Seer Inc
SEER
$123M
-94,681
Closed -$5.32M
SRPT icon
130
Sarepta Therapeutics
SRPT
$1.68B
-86,624
Closed -$14.8M
PSTX
131
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
-838,826
Closed -$9.2M
SILK
132
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
-399,483
Closed -$25.2M
DCPH
133
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-488,842
Closed -$27.9M
AFIB
134
DELISTED
Acutus Medical Inc
AFIB
-982,236
Closed -$28.3M
SGTX
135
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
-17,308
Closed -$10.8M

Similar funds

Sectoral Asset Management's Q1 2021 Portfolio in Review

As of Q1 2021, Sectoral Asset Management held 135 positions worth $1.32B, down 7% from $1.42B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Sectoral Asset Management withdrew a net $118M in Q1 2021, closing 22 positions and reducing 44 holdings. Its most notable exit was Acadia Pharmaceuticals, an estimated $35M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 97% a quarter earlier, followed by Industrials.

Against the trend, Sectoral Asset Management opened a new position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares worth $33.4M.

  • Sectoral Asset Management's largest Q1 2021 buy was Ortho Clinical Diagnostics Holdings plc Ordinary Shares: 1,730,500 shares worth $33.4M.
  • Sectoral Asset Management added most to TG Therapeutics in Q1 2021, an estimated $14.8M increase.
  • Sectoral Asset Management's biggest Q1 2021 reduction was Tandem Diabetes Care, cutting an estimated $40.6M.
  • Sectoral Asset Management fully exited Acadia Pharmaceuticals in Q1 2021, selling an estimated $35M.
  • Sectoral Asset Management's ten largest holdings make up 28% of its $1.32B portfolio in Q1 2021.
  • Sectoral Asset Management opened 38 new positions and closed 22 in Q1 2021.
  • Sectoral Asset Management's portfolio value fell 7% quarter-over-quarter to $1.32B.

Based on Sectoral Asset Management's 13F filing for Q1 2021, filed 14 May 2021.